Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SCYNEXIS Announces Positive Results of Oral Ibrexafungerp to Treat Severe Fungal Infections

americanpharmaceuticalreviewMarch 05, 2021

Tag: SCYNEXIS , Ibrexafungerp , CARES , FURI

PharmaSources Customer Service